From Bottlenecks to Breakthroughs: Scaling Molecular Testing with OpenArray

At Livingston Med Lab in central Texas, the team has long prided itself on doing quality molecular medicine work including qPCR, array cards, and infectious disease panels, and always pushing to offer more to its community. But a roadblock emerged when they asked: how do we scale more efficiently without sacrificing cost or quality?

Sean Villasana is molecular lab supervisor technical respresentative at Livingston Med Lab
Sean Villasana is molecular lab supervisor technical respresentative at Livingston Med Lab

The Challenge: Maximizing Throughput

Livingston Med Lab runs moderate to high complexity testing in molecular medicine, immunology, hematology, chemistry, allergies and plans to grow into next‑generation sequencing and full toxicology. One key challenge: figuring out which technology to use when, especially given variable sample volumes.

They’d used array cards in the past, but array cards have limits: lower throughput, certain workflow constraints, and sometimes cost inefficiencies when sample numbers increase. When looking at OpenArray technology on the QuantStudio™ 12K Flex system, questions arose:

  • When is OpenArray better than array cards?
  • What throughput can realistically be achieved?
  • What are the cost trade‑offs, and when does the extra investment in reagent and  consumables pay off?

These are questions many labs face when balancing precision, speed, and cost.

Bringing in the Field Application Scientist (FAS)

Enter John Pfeifer, Thermo Fisher’s Field Application Scientist. Livingston’s molecular lab supervisor, Sean Villasana, describes the FAS’s role as crucial:

  • First, John helped break down when each technology makes sense, not just the “how.”
  • He walked through the methods for OpenArray-how to set it up, run it, get good data, what pitfalls to avoid.
  • Importantly, the help was remote (and sometimes onsite) but always hands‑on: step by step guidance, including tips & tricks.

The remote support made a big difference-not just for speed of resolution but for cost. For example, eliminating the need for outside contractors to fix or set up certain workflows saved Livingston Med Lab an estimated $60,000–$80,000 in one year just for their HIV testing workflow.

The Turning Point: From Modest to Massive Throughput

With guidance from the FAS, Livingston recalibrated how they use OpenArray vs array cards. The results were dramatic:

  • By switching from array cards (low volume panels) to OpenArray for high‑volume infectious disease panels, they could run 4 OpenArray plates simultaneously, drastically increasing daily sample throughput.
  • Where they once were handling small numbers (e.g. 7 samples on a card), they now manage ~23 in a similar timeframe using OpenArray.

Overall, this contributed to nearly 900% scale‑up in daily production.

Figure . by improving their use of OpenArray technology, Livingston Med Lab has been able to maximize their sample throughput daily, resulting in an increase in production of ~900%, since 4 open array plates can re run at a time.

Strategy Lessons: Matching the Right Tool to the Right Job

The key to success wasn’t simply adopting a new technology-it was leveraging it strategically. Livingston implemented a blended approach:

Panel TypeWhen To Use Array CardsWhen To Use OpenArray
Low sample volume / smaller panels  Use array cards (lower upfront consumable cost)Not cost-effective to use OpenArray
High sample volume / high throughput panelsArray cards too slow, less scalableOpenArray is faster, more samples, better throughput

By knowing clearly which panel to route to which platform, and by leveraging the training and support from their FAS, they avoided waste and maximized production where it counts.

The Impact: What This Means for Labs Like Yours

If you run molecular diagnostics, this case has some key takeaways:

  • Don’t assume “faster tech = always better.” It depends on your sample load and your panel type.
  • Training and support matter. Having a partner who understands both your lab’s constraints and the biology behind the methods accelerates learning and pays off.
  • Remote support can give big savings in both time and money. Especially when dealing with unfamiliar technologies or optimizing workflows.
  • Scalability isn’t just buying expensive instruments. It’s about process: choosing when to switch platforms, optimizing reagent use, and running multiple plates efficiently.

Resources:

Written by:

John Pfeifer, PhD

Sr. Real-Time PCR Field Applications Scientist, Thermo Fisher Scientific

John Pfeifer joined Perkin Elmer Corp in 1991 supporting PCR. In 1996, he became one of the first FAS to support the new real-time PCR product line, a role which he continues today.

Read more Pfeifer, John

Leave a Reply

Your email address will not be published. Required fields are marked *

Get news and research reviews on the topic of your choice, right in your inbox.

Subscribe Now

  • This field is for validation purposes and should be left unchanged.